BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sýkora J, Pomahačová R, Kreslová M, Cvalínová D, Štych P, Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol 2018; 24(25): 2741-2763 [PMID: 29991879 DOI: 10.3748/wjg.v24.i25.2741] [Cited by in CrossRef: 161] [Cited by in F6Publishing: 132] [Article Influence: 40.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Peng K, Li G, Wan L, Xu T, Cui Z, Xiao F, Li L, Liu Z, Zhang L, Tang G. Evaluation of bone mineral density and body compositions interrelation in young and middle-aged male patients with Crohn’s disease by quantitative computed tomography. Front Endocrinol 2022;13:953289. [DOI: 10.3389/fendo.2022.953289] [Reference Citation Analysis]
2 Li S, Kern I, Manuwald U, Kugler J, Rothe U. Application of the capture–recapture method to ascertain the completeness of the Saxon pediatric IBD registry in Germany. J Public Health (Berl ). [DOI: 10.1007/s10389-022-01749-5] [Reference Citation Analysis]
3 Kim C, Yin Z, Kamdar N, Stidham R. Vaccination Against Measles, Mumps, Rubella and Incident Inflammatory Bowel Disease in a National Cohort of Privately Insured Children. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izac176] [Reference Citation Analysis]
4 Dipasquale V, Romano C. Genes vs environment in inflammatory bowel disease: an update. Expert Rev Clin Immunol 2022. [PMID: 35912838 DOI: 10.1080/1744666X.2022.2108407] [Reference Citation Analysis]
5 Lee GW, Chew KS, Wong SY, Chong SY, Ong SY, Lee WS. Quality of life in Malaysian children with inflammatory bowel disease: An understudied population. J Paediatr Child Health 2022. [PMID: 35880617 DOI: 10.1111/jpc.16130] [Reference Citation Analysis]
6 Martins AL, Fróes RSB, Zago-Gomes MP. Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil. World J Clin Pediatr 2022; 11(4): 341-350 [DOI: 10.5409/wjcp.v11.i4.341] [Reference Citation Analysis]
7 Li Y, Chen Q, Zhu W, Deng F, Li D, Li J, Wan J, Ling Hu E. Mesenchymal stem cell transplantation worsens intestinal inflammation and microenvironment in PI3Kγ-knockout mice. Cellular Immunology 2022. [DOI: 10.1016/j.cellimm.2022.104573] [Reference Citation Analysis]
8 Kang C, Yoon H, Park S, Kim J, Han K, Kim S, Koh H, Lee MJ, Shin HJ. Initial Abdominal CT and Laboratory Findings Prior to Diagnosis of Crohn's Disease in Children. Yonsei Med J 2022;63:675-82. [PMID: 35748079 DOI: 10.3349/ymj.2022.63.7.675] [Reference Citation Analysis]
9 Prasad H, Mathew JKK, Visweswariah SS. Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities. Front Endocrinol 2022;13:911459. [DOI: 10.3389/fendo.2022.911459] [Reference Citation Analysis]
10 Jagt JZ, Verburgt CM, de Vries R, de Boer NKH, Benninga MA, de Jonge WJ, van Limbergen JE, de Meij TGJ. Faecal metabolomics in paediatric inflammatory bowel disease: a systematic review. J Crohns Colitis 2022:jjac079. [PMID: 35679608 DOI: 10.1093/ecco-jcc/jjac079] [Reference Citation Analysis]
11 Lund K, Larsen MD, Knudsen T, Kjeldsen J, Nielsen RG, Brage S, Nørgård BM. Physical activity measured by accelerometry in paediatric and young adult patients with inflammatory bowel disease. BMC Gastroenterol 2022;22:290. [PMID: 35672666 DOI: 10.1186/s12876-022-02358-y] [Reference Citation Analysis]
12 Dow CT, Alvarez BL. Mycobacterium paratuberculosis zoonosis is a One Health emergency. Ecohealth 2022. [PMID: 35655048 DOI: 10.1007/s10393-022-01602-x] [Reference Citation Analysis]
13 Bennett Murphy LM, O’gorman M, Fitzgerald S, Peterson K, Robson J. Quality of life in children and adolescents with eosinophilic esophagitis. Children's Health Care. [DOI: 10.1080/02739615.2022.2079510] [Reference Citation Analysis]
14 Yusuf K, Saha S, Umar S. Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease. Biomedicines 2022;10:1242. [DOI: 10.3390/biomedicines10061242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Arcucci MS, Contreras MB, Gallo J, Antoniska MA, Busoni V, Tennina C, D'Agostino D, Kakisu MH, Weyersberg C, Orsi M. Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years. Pediatr Gastroenterol Hepatol Nutr 2022;25:218-27. [PMID: 35611373 DOI: 10.5223/pghn.2022.25.3.218] [Reference Citation Analysis]
16 Kelsen J, Dawany N, Conrad M, Patel T, Devoto M, Maurer K, Sullivan KE. Clinical and laboratory predictors of monogenic very early onset inflammatory bowel disease. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109047] [Reference Citation Analysis]
17 Xu L, Huang G, Cong Y, Yu Y, Li Y. Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones. Inflamm Bowel Dis 2022:izac094. [PMID: 35486387 DOI: 10.1093/ibd/izac094] [Reference Citation Analysis]
18 Zhang XY, Dong HC, Wang WF, Zhang Y. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis. World J Gastroenterol 2022; 28(16): 1705-1717 [DOI: 10.3748/wjg.v28.i16.1705] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kikut J, Drozd A, Mokrzycka M, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Are EPA and DHA Derivatives Involved in IBD Remission? JCM 2022;11:2388. [DOI: 10.3390/jcm11092388] [Reference Citation Analysis]
20 Wlazło M, Kierkuś J. Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature. JCM 2022;11:2004. [DOI: 10.3390/jcm11072004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Chugh R, Gaidos JK. Fertility and Pregnancy in Crohn's Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.12.012] [Reference Citation Analysis]
22 Kikut J, Mokrzycka M, Drozd A, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC). JCM 2022;11:1861. [DOI: 10.3390/jcm11071861] [Reference Citation Analysis]
23 Lee YJ, Hwang JY, Ryu H, Kim TU, Kim YW, Park JH, Choo KS, Nam KJ, Roh J. Image quality and diagnostic accuracy of reduced-dose computed tomography enterography with model-based iterative reconstruction in pediatric Crohn's disease patients. Sci Rep 2022;12:2147. [PMID: 35140296 DOI: 10.1038/s41598-022-06246-z] [Reference Citation Analysis]
24 Alvisi P, Labriola F, Scarallo L, Gandullia P, Knafelz D, Bramuzzo M, Zuin G, Pastore MR, Illiceto MT, Miele E, Graziano F, Romano C, Bartoletti D, Oliva S, Arrigo S, Bracci F, Renzo S, Agrusti A, Aloi M, Lionetti P; SIGENP IBD Working Group. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry. Dig Liver Dis 2022:S1590-8658(22)00001-9. [PMID: 35125313 DOI: 10.1016/j.dld.2021.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Luo H, Cao G, Luo C, Tan D, Vong CT, Xu Y, Wang S, Lu H, Wang Y, Jing W. Emerging Pharmacotherapy for Inflammatory Bowel Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Labriola F, Marcato C, Zarbo C, Betti L, Catelli A, Valerii MC, Spisni E, Alvisi P. Dietary Habits of a Group of Children with Crohn’s Disease Compared to Healthy Subjects: Assessment of Risk of Nutritional Deficiencies through a Bromatological Analysis. Nutrients 2022;14:499. [DOI: 10.3390/nu14030499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Choe JY, Choi S, Song KH, Jang HJ, Choi KH, Yi DY, Hong SJ, Hwang JH, Cho SM, Kim YJ, Choe BH, Kang B. Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the Daegu-Kyungpook Province From 2017 to 2020. Front Pediatr 2021;9:810173. [PMID: 35059365 DOI: 10.3389/fped.2021.810173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado D F, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI; InsightScope Pediatric IBD Epidemiology Group. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology 2022;162:1147-1159.e4. [PMID: 34995526 DOI: 10.1053/j.gastro.2021.12.282] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
29 Amato HK, Hemlock C, Andrejko KL, Smith AR, Hejazi NS, Hubbard AE, Verma SC, Adhikari RK, Pokhrel D, Smith K, Graham JP, Pokhrel A. Biodigester Cookstove Interventions and Child Diarrhea in Semirural Nepal: A Causal Analysis of Daily Observations. Environ Health Perspect 2022;130:17002. [PMID: 34985305 DOI: 10.1289/EHP9468] [Reference Citation Analysis]
30 D'Arcangelo G, Abi Nader E, Charbit-Henrion F, Talbotec C, Goulet O, Ruemmele FM, Pigneur B. Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study. J Pediatr Gastroenterol Nutr 2022;74:79-84. [PMID: 34962501 DOI: 10.1097/MPG.0000000000003301] [Reference Citation Analysis]
31 Hu W, Feng Y, Ye Z, Tang Z, Qian L, Wang Y, Huang Y. The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China. Front Pediatr 2021;9:744599. [PMID: 34966700 DOI: 10.3389/fped.2021.744599] [Reference Citation Analysis]
32 Rodrigues M, Bueno C, Lomazi EA, Fernandes MIM, Neufeld CB, D'Amico MFM, Patiño FRA. CLASSICAL SEROLOGICAL MARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE IN BRAZIL. Arq Gastroenterol 2021;58:495-503. [PMID: 34909856 DOI: 10.1590/S0004-2803.202100000-89] [Reference Citation Analysis]
33 Shariff S, Moran G, Grimes C, Cooney RM. Current Use of EEN in Pre-Operative Optimisation in Crohn's Disease. Nutrients 2021;13:4389. [PMID: 34959941 DOI: 10.3390/nu13124389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Schwarz J, Vecka M, Stožický F, Pomahačová R, Staňková B, Tvrzická E, Kreslová M, Zahálková R, Sýkora J. The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease. Physiol Res 2021;70:799-808. [PMID: 34505533 DOI: 10.33549/physiolres.934665] [Reference Citation Analysis]
35 Um SH, Lee SW, Song KH, Lee SM, Choe BH, Lee YM, Kang B. Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? Pediatr Gastroenterol Hepatol Nutr 2021;24:564-70. [PMID: 34796101 DOI: 10.5223/pghn.2021.24.6.564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH, Choe BH, Kang B; Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis. J Korean Med Sci 2021;36:e278. [PMID: 34783212 DOI: 10.3346/jkms.2021.36.e278] [Reference Citation Analysis]
37 Lee WS, Song ZL, Wong SY, Gan CW, Koay ZL, Em JM, Chong SY, Lim CB, Wong SY, Chew KS, Kam CC. Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health 2021. [PMID: 34761458 DOI: 10.1111/jpc.15830] [Reference Citation Analysis]
38 Dupont-Lucas C, Marion-Letellier R, Pala M, Guerin C, Bôle-Feysot C, Salameh E, Goichon A, Nicol L, Aziz M, Savoye-Collet C, Savoye G. Magnetic resonance colonography assessment of acute trinitrobenzene sulfonic acid colitis in pre-pubertal rats. PLoS One 2021;16:e0259135. [PMID: 34735489 DOI: 10.1371/journal.pone.0259135] [Reference Citation Analysis]
39 Madrazo-de la Garza JA. Editorial comment on the epidemiologic trend of pediatric inflammatory bowel disease in Latin America: The Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) Working Group. Rev Gastroenterol Mex (Engl Ed) 2021;86:325-7. [PMID: 34389289 DOI: 10.1016/j.rgmxen.2021.04.001] [Reference Citation Analysis]
40 Hellmann J, Andersen H, Fei L, Linn A, Bezold R, Lake K, Jackson K, Meyer D, Dirksing K, Bonkowski E, Ollberding NJ, Haslam DB, Denson L. Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Inflamm Bowel Dis 2020;26:1212-21. [PMID: 31725875 DOI: 10.1093/ibd/izz263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 van Straalen JW, Krol RM, Giancane G, Panaviene V, Ailioaie LM, Doležalová P, Cattalini M, Susic G, Sztajnbok F, Maritsi D, Constantin T, Sawhney S, Rygg M, Oliveira SK, Nordal EB, Saad-Magalhaes C, Rubio-Perez N, Jelusic M, de Roock S, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO). Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology (Oxford) 2021:keab678. [PMID: 34508559 DOI: 10.1093/rheumatology/keab678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Gatti S, Del Baldo G, Catassi G, Faragalli A, Aloi M, Bramuzzo M, D'Arcangelo G, Felici E, Fuoti M, Lega S, Panceri R, Pastore M, Penagini F, Gesuita R, Catassi C. Factors associated with quality of life in Italian children and adolescents with IBD. Sci Rep 2021;11:18076. [PMID: 34508152 DOI: 10.1038/s41598-021-97661-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Jabandziev P, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:985-93. [PMID: 32009179 DOI: 10.1093/ibd/izaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
44 Jones CMA, Connors J, Dunn KA, Bielawski JP, Comeau AM, Langille MGI, Van Limbergen J. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease. Inflamm Bowel Dis 2020;26:1026-37. [PMID: 31961432 DOI: 10.1093/ibd/izaa001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
45 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Yang C, Yu H, Hu X, Chen H, Wu H, Deng C, Sun N. Gold‐Doped Covalent Organic Framework Reveals Specific Serum Metabolic Fingerprints as Point of Crohn's Disease Diagnosis. Adv Funct Materials 2021;31:2105478. [DOI: 10.1002/adfm.202105478] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
47 Rao A, Puertolas M, Runde J. COVID-19 and Gastrointestinal and Hepatobiliary Diseases. Pediatr Ann 2021;50:e315-9. [PMID: 34398713 DOI: 10.3928/19382359-20210721-02] [Reference Citation Analysis]
48 Winther SA, Mannerla MM, Frimodt-Møller M, Persson F, Hansen TW, Lehto M, Hörkkö S, Blaut M, Forsblom C, Groop PH, Rossing P. Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy. Sci Rep 2021;11:15208. [PMID: 34312454 DOI: 10.1038/s41598-021-94747-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Gargallo-Puyuelo CJ, Laredo V, Gomollón F. Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era? Front Med (Lausanne) 2021;8:681907. [PMID: 34336887 DOI: 10.3389/fmed.2021.681907] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Tang YH, Liu HC, Song G, Wu TT, Zhao Y, Shi LJ. A case-control study on the association of intestinal flora with ulcerative colitis. AMB Express 2021;11:106. [PMID: 34264407 DOI: 10.1186/s13568-021-01267-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kim MJ, Kim E, Kang B, Choe YH. Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease. J Pediatr Gastroenterol Nutr 2021;72:870-6. [PMID: 33908743 DOI: 10.1097/MPG.0000000000003070] [Reference Citation Analysis]
52 Kvedaraite E. Neutrophil-T cell crosstalk in inflammatory bowel disease. Immunology 2021. [PMID: 34240423 DOI: 10.1111/imm.13391] [Reference Citation Analysis]
53 Newton L, Delbecque L, Coşkun U, Symonds T, Clegg J, Hunter T. A qualitative study to explore symptoms and impacts of pediatric and adolescent Crohn's disease from patient and caregiver perspective. J Patient Rep Outcomes 2021;5:49. [PMID: 34170423 DOI: 10.1186/s41687-021-00321-1] [Reference Citation Analysis]
54 Kim PH, Yoon HM, Jung AY, Lee JS, Cho YA. Diagnostic Performance of Diffusion-weighted Imaging for Evaluation of Bowel Inflammation in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2021:jjab111. [PMID: 34159379 DOI: 10.1093/ecco-jcc/jjab111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Li CM, Chen Z. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Front Cell Dev Biol 2021;9:664305. [PMID: 34235145 DOI: 10.3389/fcell.2021.664305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
56 Croft NM, Faubion WA Jr, Kugathasan S, Kierkus J, Ruemmele FM, Shimizu T, Mostafa NM, Venetucci M, Finney-Hayward T, Sanchez Gonzalez Y, Bereswill M, Lazar A, Turner D. Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study. Lancet Gastroenterol Hepatol 2021;6:616-27. [PMID: 34153231 DOI: 10.1016/S2468-1253(21)00142-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
57 Ronel N, Tzion RL, Orlanski-Meyer E, Shteyer E, Guz-Mark A, Assa A, Strich D, Turner D, Ledder O. Clinical Criteria Can Identify Children With Osteopenia in Newly Diagnosed Crohn Disease. J Pediatr Gastroenterol Nutr 2021;72:270-5. [PMID: 32810035 DOI: 10.1097/MPG.0000000000002911] [Reference Citation Analysis]
58 Jabandziev P, Pinkasova T, Kunovsky L, Papez J, Jouza M, Karlinova B, Novackova M, Urik M, Aulicka S, Slaby O, Bohosova J, Bajerova K, Bajer M, Goel A. Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017). J Pediatr Gastroenterol Nutr 2020;70:586-92. [PMID: 32058417 DOI: 10.1097/MPG.0000000000002660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tulumović E, Salkić N, Tulumović D. Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up. World J Gastroenterol 2021; 27(20): 2630-2642 [PMID: 34092980 DOI: 10.3748/wjg.v27.i20.2630] [Reference Citation Analysis]
60 Liles E, Irving SA, Dandamudi P, Belongia EA, Daley MF, DeStefano F, Jackson LA, Jacobsen SJ, Kharbanda E, Klein NP, Weintraub E, Naleway AL. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine 2021;39:3614-20. [PMID: 34052066 DOI: 10.1016/j.vaccine.2021.05.032] [Reference Citation Analysis]
61 Choi S, Moon W. [Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?]. Korean J Gastroenterol 2021;77:220-6. [PMID: 34035199 DOI: 10.4166/kjg.2021.067] [Reference Citation Analysis]
62 Tang J, Xu D, Dong X, Wang Y, Wang K, Wang Y, Qiao T, Cui Y. Potential of phytomedicine in the treatment of inflammatory bowel disease. Phytochem Rev. [DOI: 10.1007/s11101-021-09760-6] [Reference Citation Analysis]
63 Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of Adipose Tissue in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:4226. [PMID: 33921758 DOI: 10.3390/ijms22084226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 Luo H, Vong CT, Tan D, Zhang J, Yu H, Yang L, Zhang C, Luo C, Zhong Z, Wang Y. Panax notoginseng Saponins Modulate the Inflammatory Response and Improve IBD-Like Symptoms via TLR/NF-[Formula: see text]B and MAPK Signaling Pathways. Am J Chin Med 2021;49:925-39. [PMID: 33829964 DOI: 10.1142/S0192415X21500440] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
65 Yu Y, Zhao H, Luo Y, Lou J, Chen J, Fang Y. Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy. Dig Dis Sci. 2021;. [PMID: 33818661 DOI: 10.1007/s10620-021-06917-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Vernon-roberts A, Gearry RB, Day AS. Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease. GastrointestDisord 2021;3:61-77. [DOI: 10.3390/gidisord3020007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Jabandziev P, Kakisaka T, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification. J Clin Med 2021;10:1325. [PMID: 33806966 DOI: 10.3390/jcm10061325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
68 Giannoudaki E, Gargan S, Hussey S, Long A, Walsh PT. Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease. Front Pediatr 2021;9:640497. [PMID: 33816403 DOI: 10.3389/fped.2021.640497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Jin G, Tang Q, Ma J, Liu X, Zhou B, Sun Y, Pang X, Guo Z, Xie R, Liu T, Wang B, Cao H. Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood. mSystems 2021;6:e01337-20. [PMID: 33727402 DOI: 10.1128/mSystems.01337-20] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
70 Chen QL, Yin HR, He QY, Wang Y. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease. Biomed Pharmacother 2021;138:111442. [PMID: 33667791 DOI: 10.1016/j.biopha.2021.111442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
71 Kamphorst K, Van Daele E, Vlieger AM, Daams JG, Knol J, van Elburg RM. Early life antibiotics and childhood gastrointestinal disorders: a systematic review. BMJ Paediatr Open 2021;5:e001028. [PMID: 33748435 DOI: 10.1136/bmjpo-2021-001028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zeng W, He D, Xing Y, Liu J, Su N, Zhang C, Wang Y, Xing X. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021;10:119-30. [DOI: 10.1016/j.fshw.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Szántó KJ, Balázs T, Schrempf DM, Farkas K, Molnár T. Does inflammatory bowel disease have different characteristics according to stage of adolescence? Therap Adv Gastroenterol 2021;14:1756284820986670. [PMID: 33717208 DOI: 10.1177/1756284820986670] [Reference Citation Analysis]
74 Adamina M, Gerasimidis K, Sigall-Boneh R, Zmora O, de Buck van Overstraeten A, Campmans-Kuijpers M, Ellul P, Katsanos K, Kotze PG, Noor N, Schäfli-Thurnherr J, Vavricka S, Wall C, Wierdsma N, Yassin N, Lomer M. Perioperative Dietary Therapy in Inflammatory Bowel Disease.J Crohns Colitis. 2020;14:431-444. [PMID: 31550347 DOI: 10.1093/ecco-jcc/jjz160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
75 Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Reference Citation Analysis]
76 Singh H, Nguyen T, Pho C, Giles E. Early Infliximab in Crohn's is associated with decreased intestinal surgery and similar health care costs. Scand J Gastroenterol 2021;56:397-402. [PMID: 33595389 DOI: 10.1080/00365521.2021.1880626] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Chan JM, Carroll MW, Smyth M, Hamilton Z, Evans D, McGrail K, Benchimol EI, Jacobson K. Comparing Health Administrative and Clinical Registry Data: Trends in Incidence and Prevalence of Pediatric Inflammatory Bowel Disease in British Columbia. Clin Epidemiol 2021;13:81-90. [PMID: 33603489 DOI: 10.2147/CLEP.S292546] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Berkovitch G, Cohen S, Lubetzky R, Singer D, Yerushalmy-Feler A. Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD. BMC Pediatr 2021;21:63. [PMID: 33541320 DOI: 10.1186/s12887-021-02526-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease. Pharmacol Rep 2021;73:700-11. [PMID: 33462754 DOI: 10.1007/s43440-020-00213-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, Yoo HW, Choi JH. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr 2021;21:35. [PMID: 33446154 DOI: 10.1186/s12887-021-02496-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
81 Adamina M, Feakins R, Iacucci M, Spinelli A, Cannatelli R, D'Hoore A, Driessen A, Katsanos K, Mookhoek A, Myrelid P, Pellino G, Peros G, Tontini GE, Tripathi M, Yanai H, Svrcek M. ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology. J Crohns Colitis 2021;15:1089-105. [PMID: 33428711 DOI: 10.1093/ecco-jcc/jjab011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
82 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
83 Cococcioni L, Panelli S, Varotto-boccazzi I, Carlo DD, Pistone D, Leccese G, Zuccotti GV, Comandatore F. IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota. Digestive and Liver Disease 2021;53:17-25. [DOI: 10.1016/j.dld.2020.10.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Shearer JL, Perry S, Lidyard N, Apperson-Hensen C, DeLozier S, Burkhart K, Katz J, Moses J. Evaluating a Standardized Transition of Care Process for Pediatric Inflammatory Bowel Disease Patients. Children (Basel) 2020;7:E271. [PMID: 33291611 DOI: 10.3390/children7120271] [Reference Citation Analysis]
85 Johnson LE, Lee MJ, Turner-Moore T, Grinsted Tate LR, Brooks AJ, Tattersall RS, Jones GL, Lobo AJ. Systematic Review of Factors Affecting Transition Readiness Skills in Patients with Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1049-59. [PMID: 33252669 DOI: 10.1093/ecco-jcc/jjaa245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
86 Ha C, Kim ES, Kwon Y, Choe YH, Kim MJ, Lee SY. The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease. Pharmgenomics Pers Med 2020;13:665-71. [PMID: 33273844 DOI: 10.2147/PGPM.S279446] [Reference Citation Analysis]
87 Araruna ME, Serafim C, Alves Júnior E, Hiruma-Lima C, Diniz M, Batista L. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review. Molecules 2020;25:E5430. [PMID: 33233487 DOI: 10.3390/molecules25225430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Kim ES, Kwon Y, Choe YH, Kim MJ. Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients. Sci Rep 2020;10:19032. [PMID: 33149222 DOI: 10.1038/s41598-020-75938-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
89 van Hoeve K, Vermeire S. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place. Paediatr Drugs 2020;22:449-61. [PMID: 32797366 DOI: 10.1007/s40272-020-00411-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Li A, Ni W, Li Y, Zhang X, Yang J, Ma X, Jia X, Li C, Liu L. Effect of 2′-fucosyllactose supplementation on intestinal flora in mice with intestinal inflammatory diseases. International Dairy Journal 2020;110:104797. [DOI: 10.1016/j.idairyj.2020.104797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
91 Mishra R, Dhawan P, Srivastava AS, Singh AB. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World J Stem Cells 2020; 12(10): 1050-1066 [PMID: 33178391 DOI: 10.4252/wjsc.v12.i10.1050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
92 Shi L, Han X, Li JX, Liao YT, Kou FS, Wang ZB, Shi R, Zhao XJ, Sun ZM, Hao Y. Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses. World J Gastroenterol 2020; 26(39): 5983-5996 [PMID: 33132649 DOI: 10.3748/wjg.v26.i39.5983] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
93 Karaskova E, Pospisilova D, Velganova-Veghova M, Geryk M, Volejnikova J, Holub D, Hajduch M. Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease. Dig Dis Sci 2021;66:3263-9. [PMID: 33063192 DOI: 10.1007/s10620-020-06652-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Medina Carbonell FR, Choyudhry Chandan O. Body Mass Index at Presentation of Inflammatory Bowel Disease in Children. Pediatr Gastroenterol Hepatol Nutr 2020;23:439-46. [PMID: 32953639 DOI: 10.5223/pghn.2020.23.5.439] [Reference Citation Analysis]
95 Kostoff RN, Briggs MB, Shores DR. Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation. World J Gastroenterol 2020; 26(33): 4889-4899 [PMID: 32952337 DOI: 10.3748/wjg.v26.i33.4889] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
96 Martín-Merino E, Martín-Pérez M, Castillo-Cano B, Montero-Corominas D. The recording and prevalence of Inflammatory bowel disease in girls' primary care medical Spanish records. Pharmacoepidemiol Drug Saf 2020;29:1440-9. [PMID: 32885513 DOI: 10.1002/pds.5107] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan GG, Lix LM. Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults. J Can Assoc Gastroenterol 2021;4:186-93. [PMID: 34337319 DOI: 10.1093/jcag/gwaa028] [Reference Citation Analysis]
98 Khaki-Khatibi F, Qujeq D, Kashifard M, Moein S, Maniati M, Vaghari-Tabari M. Calprotectin in inflammatory bowel disease. Clin Chim Acta 2020;510:556-65. [PMID: 32818491 DOI: 10.1016/j.cca.2020.08.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
99 Srivastava A, Sathiyasekharan M, Jagadisan B, Bolia R, Peethambaran M, Mammayil G, Acharya B, Malik R, Sankaranarayanan S, Biradar V, Malhotra S, Philip M, Poddar U, Yachha SK. Paediatric inflammatory bowel disease in India: a prospective multicentre study. Eur J Gastroenterol Hepatol 2020;32:1305-11. [PMID: 32796356 DOI: 10.1097/MEG.0000000000001859] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Yeh PJ, Chen CC, Chao HC, Lai JY, Hsueh C, Wang CJ, Lai MW. High initial bowel resection rate and very-early-onset inflammatory bowel disease - A challenge in a low-prevalence area. J Formos Med Assoc 2021;120:720-7. [PMID: 32819795 DOI: 10.1016/j.jfma.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Czubkowski P, Osiecki M, Szymańska E, Kierkuś J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med 2020;20:481-91. [PMID: 32785793 DOI: 10.1007/s10238-020-00639-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 El-Shabrawi MH, Tarek S, Abou-Zekri M, Meshaal S, Enayet A, Mogahed EA. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country. World J Gastrointest Pharmacol Ther 2020; 11(3): 48-58 [PMID: 32844043 DOI: 10.4292/wjgpt.v11.i3.48] [Reference Citation Analysis]
103 Ivković L, Hojsak I, Trivić I, Sila S, Hrabač P, Konjik V, Senečić-Čala I, Palčevski G, Despot R, Žaja O, Kolaček S. Incidence and Geographical Variability of Pediatric Inflammatory Bowel Disease in Croatia: Data From the Croatian National Registry for Children With Inflammatory Bowel Disease. Clin Pediatr (Phila) 2020;59:1182-90. [PMID: 32674589 DOI: 10.1177/0009922820941202] [Reference Citation Analysis]
104 Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Russell RK, Walters TD, Ruemmele FM, Samsom JN, Croft NM, de Ridder L; PIBD-SETQuality consortium and PIBD-NET. International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open 2020;10:e035538. [PMID: 32611739 DOI: 10.1136/bmjopen-2019-035538] [Reference Citation Analysis]
105 Denning NL, Kallis MP, Kvasnovsky CL, Lipskar AM. Outcomes of Initial Subtotal Colectomy for Pediatric Inflammatory Bowel Disease. J Surg Res 2020;255:319-24. [PMID: 32593890 DOI: 10.1016/j.jss.2020.05.026] [Reference Citation Analysis]
106 Keyashian K, Dehghan M, Sceats L, Kin C, Limketkai BN, Park KT. Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States. Inflamm Bowel Dis 2019;25:1983-9. [PMID: 31095681 DOI: 10.1093/ibd/izz092] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
107 Li P, Wang Y, Luo J, Zeng Q, Wang M, Bai M, Zhou H, Wang J, Jiang H. Downregulation of OCTN2 by cytokines plays an important role in the progression of inflammatory bowel disease. Biochem Pharmacol 2020;178:114115. [PMID: 32579962 DOI: 10.1016/j.bcp.2020.114115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Appleton L, Watt E, Jagger F, Hansen R, Gearry RB, Day AS. Associations between the Presence of Granulomata and Disease Phenotype and Outcomes in Children Diagnosed with Crohn’s Disease. GastrointestDisord 2020;2:164-70. [DOI: 10.3390/gidisord2020017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Murphy LK, de la Vega R, Kohut SA, Kawamura JS, Levy RL, Palermo TM. Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:697-710. [PMID: 32458966 DOI: 10.1093/ibd/izaa115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Colquhoun C, Duncan M, Grant G. Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis. Diseases 2020;8:E13. [PMID: 32397606 DOI: 10.3390/diseases8020013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
111 Poddar U, Yachha SK, Srivastava A, Kumari N. Pediatric inflammatory bowel disease: Is it really uncommon in Asian children? JGH Open 2020;4:860-6. [PMID: 33102756 DOI: 10.1002/jgh3.12330] [Reference Citation Analysis]
112 Schnell A, Schwarz B, Wahlbuhl M, Allabauer I, Hess M, Weber S, Werner F, Schmidt H, Rechenauer T, Siebenlist G, Kaspar S, Ehrsam C, Rieger D, Rückel A, Metzler M, Christoph J, Woelfle J, Rascher W, Hoerning A. Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy. Inflamm Bowel Dis 2021;27:224-35. [PMID: 32185399 DOI: 10.1093/ibd/izaa054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Godin JP, Martin FP, Breton I, Schoepfer A, Nydegger A. Total and activity-induced energy expenditure measured during a year in children with inflammatory bowel disease in clinical remission remain lower than in healthy controls. Clin Nutr 2020;39:3147-52. [PMID: 32147199 DOI: 10.1016/j.clnu.2020.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Filimoniuk A, Daniluk U, Samczuk P, Wasilewska N, Jakimiec P, Kucharska M, Lebensztejn DM, Ciborowski M. Metabolomic profiling in children with inflammatory bowel disease. Adv Med Sci 2020;65:65-70. [PMID: 31901795 DOI: 10.1016/j.advms.2019.12.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
115 Borg-Bartolo SP, Boyapati RK, Satsangi J, Kalla R. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res. 2020;9. [PMID: 32047622 DOI: 10.12688/f1000research.20928.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
116 Kang B, Kim JE, Jung JH, Choe JY, Kim MJ, Choe YH, Kim S, Koh H, Lee YM, Lee JH, Lee Y, Lee JH, Lee HJ, Jang HJ, Choi Y, Choi SY, Kim JY, Choe BH. Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts. Pediatr Gastroenterol Hepatol Nutr 2020;23:49-62. [PMID: 31988875 DOI: 10.5223/pghn.2020.23.1.49] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
117 Li Y, Chen QQ, Yuan J, Chen Z, Du HT, Wan J. Altered microbial community structure in PI3Kγ knockout mice with colitis impeding relief of inflammation: Establishment of new indices for intestinal microbial disorder. Int Immunopharmacol 2020;79:105901. [PMID: 31896510 DOI: 10.1016/j.intimp.2019.105901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Huang JG, Aw MM. Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history. Pediatr Neonatol 2020;61:263-71. [PMID: 32005607 DOI: 10.1016/j.pedneo.2019.12.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
119 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
120 Alrafas HR, Busbee PB, Nagarkatti M, Nagarkatti PS. Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis. Mol Nutr Food Res 2020;64:e1900633. [PMID: 31730734 DOI: 10.1002/mnfr.201900633] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
121 Cousin C, Bevilacqua C, Roman C, Roquelaure B, Loundou A, Baumstarck K, Fabre A. MICI-MINOTS: Linguistic and metric validation of a pediatric questionnaire on knowledge about inflammatory bowel disease. Arch Pediatr. 2020;27:110-116. [PMID: 31796231 DOI: 10.1016/j.arcped.2019.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
122 Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr 2019;7:432. [PMID: 31709203 DOI: 10.3389/fped.2019.00432] [Cited by in Crossref: 27] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
123 Karaskova E, Volejnikova J, Holub D, Velganova-Veghova M, Spenerova M, Mihal V, Pospisilova D. Changes in serum hepcidin levels in children with inflammatory bowel disease during anti-inflammatory treatment. J Paediatr Child Health 2020;56:276-82. [PMID: 31411363 DOI: 10.1111/jpc.14593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
124 Hejazi R, Hasosah M. Tuberculosis, onychomycosis and immune deficiency in complicated Crohn's disease. BMJ Case Rep 2019;12:e228986. [PMID: 31383674 DOI: 10.1136/bcr-2018-228986] [Reference Citation Analysis]
125 Sullivan KE, Conrad M, Kelsen JR. Very early-onset inflammatory bowel disease: an integrated approach. Curr Opin Allergy Clin Immunol 2018;18:459-69. [PMID: 30299395 DOI: 10.1097/ACI.0000000000000484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
126 Figueroa C. Epidemiología de la enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:257-61. [DOI: 10.1016/j.rmclc.2019.06.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
127 Sen A, Stark H. Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis. World J Gastroenterol 2019; 25(23): 2846-2862 [PMID: 31249444 DOI: 10.3748/wjg.v25.i23.2846] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
128 Kelleher M, Singh R, O'Driscoll CM, Melgar S. Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease. Cytokine Growth Factor Rev 2019;47:21-31. [PMID: 31133507 DOI: 10.1016/j.cytogfr.2019.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
129 Abuquteish D, Putra J. Upper gastrointestinal tract involvement of pediatric inflammatory bowel disease: A pathological review. World J Gastroenterol 2019; 25(16): 1928-1935 [PMID: 31086461 DOI: 10.3748/wjg.v25.i16.1928] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
130 Peng J, Zheng TT, Li X, Liang Y, Wang LJ, Huang YC, Xiao HT. Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease. Front Pharmacol 2019;10:351. [PMID: 31031622 DOI: 10.3389/fphar.2019.00351] [Cited by in Crossref: 25] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
131 Kim J, Ye BD. Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key? Pediatr Gastroenterol Hepatol Nutr 2019;22:28-40. [PMID: 30671371 DOI: 10.5223/pghn.2019.22.1.28] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
132 Kim J, Ye BD. Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key? Intest Res 2019;17:24-35. [PMID: 30419636 DOI: 10.5217/ir.2018.00128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]